Parthenon Therapeutics
parthenontx.comLocations
Cambridge, MA, USA · Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2019
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as manycancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on research, the company is designing a portfolio of drug candidates to treat the right patients at the right time.
Something looks off?Open jobs at Parthenon Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.